Literature DB >> 2191299

Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance.

M Skolovsky1, R Galron, Y Kloog, A Bdolah, F E Indig, S Blumberg, G Fleminger.   

Abstract

Incubation of endothelins (ETs) with bovine kidney neutral endopeptidase (NEP) resulted in a selective two-step degradation with loss of biochemical activity. The Km of the enzyme indicated high-affinity binding, and hydrolysis was completely inhibited by phosphoramidon. The first step was nicking of the Ser5-Leu6 bond, followed by cleavage at the amino side of Ile19. The nicked peptide exhibited biochemical activities comparable to those of the intact peptide--i.e., binding to the ET receptor, induction of inositol phospholipid hydrolysis, and toxicity. The twice-cleaved product was inactive. The sarafotoxins (SRTXs) were more resistant than the ETs to NEP: for example, the half-time for ET-1 was approximately 1 hr, while it was approximately 4 hr for SRTX-b and even higher for SRTX-c. These in vitro findings may indicate a regulatory role of NEP (or similar enzymes) in the physiological inactivation of ETs. They might also help to explain why under certain physiological conditions ETs may be less toxic than SRTXs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2191299      PMCID: PMC54185          DOI: 10.1073/pnas.87.12.4702

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Vasoconstrictor effects of sarafotoxins in rabbit aorta: structure-function relationships.

Authors:  Z Wollberg; A Bdolah; E Kochva
Journal:  Biochem Biophys Res Commun       Date:  1989-07-14       Impact factor: 3.575

2.  Sarafotoxin receptors mediate phosphoinositide hydrolysis in various rat brain regions.

Authors:  Y Kloog; I Ambar; E Kochva; Z Wollberg; A Bdolah; M Sokolovsky
Journal:  FEBS Lett       Date:  1989-01-02       Impact factor: 4.124

3.  Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain.

Authors:  Y Kloog; I Ambar; M Sokolovsky; E Kochva; Z Wollberg; A Bdolah
Journal:  Science       Date:  1988-10-14       Impact factor: 47.728

4.  Characterization and localization of a novel neuroreceptor for the peptide sarafotoxin.

Authors:  I Ambar; Y Kloog; E Kochva; Z Wollberg; A Bdolah; U Oron; M Sokolovsky
Journal:  Biochem Biophys Res Commun       Date:  1988-12-30       Impact factor: 3.575

5.  Competitive interaction between endothelin and sarafotoxin: Binding and phosphoinositides hydrolysis in rat atria and brain.

Authors:  I Ambar; Y Kloog; I Schvartz; E Hazum; M Sokolovsky
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

6.  Interaction of synthetic sarafotoxin with rat vascular endothelin receptors.

Authors:  Y Hirata; H Yoshimi; F Marumo; T X Watanabe; S Kumagaye; K Nakajima; T Kimura; S Sakakibara
Journal:  Biochem Biophys Res Commun       Date:  1989-07-14       Impact factor: 3.575

Review 7.  Molecular biology and biochemistry of the endothelins.

Authors:  M Yanagisawa; T Masaki
Journal:  Trends Pharmacol Sci       Date:  1989-09       Impact factor: 14.819

8.  Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat.

Authors:  T D Warner; G de Nucci; J R Vane
Journal:  Eur J Pharmacol       Date:  1989-01-17       Impact factor: 4.432

9.  The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.

Authors:  A Inoue; M Yanagisawa; S Kimura; Y Kasuya; T Miyauchi; K Goto; T Masaki
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 10.  Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones.

Authors:  E G Erdös; R A Skidgel
Journal:  FASEB J       Date:  1989-02       Impact factor: 5.191

View more
  24 in total

Review 1.  Secretory pathways in endothelin synthesis.

Authors:  F D Russell; A P Davenport
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.

Authors:  M A Rastegar; F Marchini; G Morazzoni; A Vegh; J G Papp; J R Parratt
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

Review 3.  Long-term neprilysin inhibition - implications for ARNIs.

Authors:  Duncan J Campbell
Journal:  Nat Rev Cardiol       Date:  2016-12-15       Impact factor: 32.419

4.  Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.

Authors:  T D Warner; G H Allcock; J R Vane
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

5.  Pre- and post-natal ontogeny of neutral endopeptidase 24-11 ('enkephalinase') studied by in vitro autoradiography in the rat.

Authors:  I Dutriez; N Salès; M C Fournié-Zaluski; B P Roques
Journal:  Experientia       Date:  1992-03-15

6.  Metabolism of endothelin-1 and big endothelin-1 by recombinant neutral endopeptidase EC.3.4.24.11.

Authors:  Z A Abassi; E Golomb; R Bridenbaugh; H R Keiser
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

7.  Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma.

Authors:  N Lebel; P D'Orléans-Juste; A Fournier; P Sirois
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

8.  Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1-38] in conscious rats.

Authors:  S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

9.  Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm.

Authors:  C Plumpton; W G Haynes; D J Webb; A P Davenport
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  Changes in A-type natriuretic peptide and its receptors induced by a neutral endopeptidase inhibitor in a rat model of sepsis.

Authors:  Kanetaka Maeshiro; Shinzo Takamori; Hiroharu Mifune; Toshihiro Matsuo; Norman Y Kimura; Junichi Honda; Kazuo Shirouzu
Journal:  Surg Today       Date:  2008-02-01       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.